Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings (English)
- New search for: Henriot, S.
- New search for: Kuhn, C.
- New search for: Kettler, R.
- New search for: Da Prada, M.
- New search for: Henriot, S.
- New search for: Kuhn, C.
- New search for: Kettler, R.
- New search for: Da Prada, M.
- New search for: Tipton, K. F.
In:
Amine oxidases: function and dysfunction
;
321-326
;
1994
-
ISBN:
-
ISSN:
- Conference paper / Print
-
Title:Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings
-
Contributors:Henriot, S. ( author ) / Kuhn, C. ( author ) / Kettler, R. ( author ) / Da Prada, M. ( author ) / Tipton, K. F.
-
Conference:5th International amine oxidase workshop, Amine oxidases: function and dysfunction ; 1992 ; Galway; Ireland
-
Published in:Amine oxidases: function and dysfunction ; 321-326JOURNAL OF NEURAL TRANSMISSION SUPPLEMENTUM ; 41 ; 321-326
-
Publisher:
- New search for: Springer-Verlag
-
Publication date:1994-01-01
-
Size:6 pages
-
ISBN:
-
ISSN:
-
Type of media:Conference paper
-
Type of material:Print
-
Language:English
-
Keywords:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents conference proceedings
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3
-
Functional expression of C-terminally truncated human monoamine oxidase type A in Saccharomyces cerevisiaeWeyler, W. et al. | 1994
- 17
-
Kinetic properties of cloned human liver monoamine oxidase ARamsay, R. R. / Tan, A. K. / Weyler, W. et al. | 1994
- 27
-
Identification of human monoamine oxidase (MAO) A and B gene promotersShih, J. C. / Zhu, Q.-S. / Grimsby, J. / Chen, K. et al. | 1994
- 35
-
Some problems associated with measuring monoamine oxidase activity in the presence of sodium azideBarwell, C. J. / Ebrahimi, S. A. et al. | 1994
- 41
-
Some kinetic properties of guinea pig liver monoamine oxidaseBarwell, C. J. / Ebrahimi, S. A. et al. | 1994
- 47
-
Estimation of monoamine oxidase concentrations in soluble and membrane-bound preparations by inhibitor bindingAnderson, M. C. / Tipton, K. F. et al. | 1994
- 57
-
Monoamine oxidase and catecholamine metabolismKopin, I. J. et al. | 1994
- 69
-
Monoamine oxidase (MAO; E.C. 1.4.3.4) characteristics of platelets influenced by in vitro and in vivo ethanol on alcoholics and on control subjectsMay, T. / Rommelspacher, H. et al. | 1994
- 75
-
The effects of ethanol on rat brain monoamine oxidase activitiesDella Corte, L. / Bianchi, L. / Colivicchi, A. / Kennedy, N. P. et al. | 1994
- 83
-
Species differences in changes of heart monoamine oxidase activities with ageStrolin Benedetti, M. / Thomassin, J. / Tocchetti, P. / Dostert, P. et al. | 1994
- 89
-
Age-related changes on MAO in B1/C57 mouse tissues: a quantitative radioautographic studySaura, J. / Richards, J. G. / Mahy, N. et al. | 1994
- 95
-
The FAD dependent amine oxidases in relation to developmental state of enterocyteFogel, W. A. / Maslinski, C. et al. | 1994
- 101
-
Role of monoamine oxidase and cathecol-O-methyltransferase in the metabolism of renal dopamineFernandes, M. H. / Soares-da-Silva, P. et al. | 1994
- 107
-
Comparison of the effect of reversible and irreversible MAO inhibitors of renal nerve activity in the anesthetized ratLavian, G. / Finberg, J. P. M. / Youdim, M. B. H. et al. | 1994
- 115
-
Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic functionMcKenna, K. F. / McManus, D. J. / Baker, G. B. / Coutts, R. T. et al. | 1994
- 123
-
Modification of cerebral cortical noradrenaline release by chronic inhibition of MAO-AFinberg, J. P. M. / Pacak, K. / Goldstein, D. S. / Kopin, I. J. et al. | 1994
- 127
-
Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT~2 binding sites in rat cortexGoodnough, D. B. / Baker, G. B. et al. | 1994
- 135
-
Clorgyline effect on pineal melatonin biosynthesis in adrenalectomized rats pretreated with 6-hydroxydopamineReuss, S. / Requintina, P. J. / Riemann, R. / Oxenkrug, G. F. et al. | 1994
- 141
-
Synergistic sedative effect of selective MAO-A, but not MAO-B, inhibitors and melatonin in frogsRequintina, P. J. / Oxenkrug, G. F. / Yuwiler, A. / Oxenkrug, A. G. et al. | 1994
- 145
-
Clorgyline effect on pineal melatonin biosynthesis in roman high- and low-avoidance ratsRequintina, P. J. / Driscoll, P. / Oxenkrug, G. F. et al. | 1994
- 149
-
Reboxetine prevents the tranylcypromine-induced increase in tyramine levels in rat heartDostert, P. / Castelli, M. G. / Cicioni, P. / Strolin Benedetti, M. et al. | 1994
- 155
-
Monoamine oxidase inhibitors: effects on tryptophan concentrations in rat brainSherry-McKenna, R. L. / Wong, J. T. E. / Paetsch, P. R. / Baker, G. B. et al. | 1994
- 167
-
Behaviour of (-)-deprenyl and its analoguesMagyar, K. et al. | 1994
- 177
-
Is selegiline neuroprotective in Parkinson's disease?Gerlach, M. / Youdim, M. B. H. / Riederer, P. et al. | 1994
- 189
-
Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicityChiueh, C. C. / Huang, S.-J. / Murphy, D. L. et al. | 1994
- 197
-
Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxinNaoi, M. / Maruyama, W. / Niwa, T. / Nagatsu, T. et al. | 1994
- 207
-
Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTPSziraki, I. / Kardos, V. / Patthy, M. / Patfalusi, M. et al. | 1994
- 221
-
Is brain superoxide dismutase activity increased following chronic treatment with l-deprenyl?Lai, C. T. / Zuo, D. M. / Yu, P. H. et al. | 1994
- 231
-
Lifespan of immunosuppressed NMRI-mice is increased by deprenylFreisleben, H.-J. / Lehr, F. / Fuchs, J. et al. | 1994
- 237
-
Double blind cross over trial with deprenyl in amyotrophic lateral sclerosisJossan, S. S. / Ekblom, J. / Gudjonsson, O. / Hagbarth, K.-E. et al. | 1994
- 243
-
Monoamine oxidase-B in motor cortex and spinal cord in amyotrophic lateral sclerosis studied by quantitative autoradiographyJossan, S. S. / Ekblom, J. / Aquilonius, S.-M. / Oreland, L. et al. | 1994
- 249
-
The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N ratsOxenkrug, G. F. / Requintina, P. J. / Correa, R. M. / Yuwiler, A. et al. | 1994
- 253
-
Reactive gliosis and monoamine oxidase BEkblom, J. / Jossan, S. S. / Oreland, L. / Walum, E. et al. | 1994
- 259
-
Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseasesDelumeau, J. C. / Bentue-Ferrer, D. / Gandon, J. M. / Amrein, R. et al. | 1994
- 269
-
Can our knowledge of monoamine oxidase (MAO) help in the design of better MAO inhibitors?Dostert, P. et al. | 1994
- 281
-
Kinetic behaviour of some acetylenic indolalkylamine derivatives and their corresponding parent aminesBalsa, D. / Perez, V. / Fernandez-Alvarez, E. / Unzeta, M. et al. | 1994
- 287
-
Acetylenic and allenic derivatives of 2-(5-methoxy-1-methylindolyl)alkylamines as selective inhibitors of MAO-A and MAO-BFernandez-Garcia, C. / Marco, J. L. / Fernandez-Alvarez, E. et al. | 1994
- 291
-
Interactions between substituted tryptamine analogues, MAO inhibitors and cytochrome P-450Valoti, M. / Costanzo, M. / Perez, V. / Unzeta, M. et al. | 1994
- 295
-
Inhibition of monoamine oxidase by clorgyline analoguesO'Brien, E. M. / Tipton, K. F. / Meroni, M. / Dostert, P. et al. | 1994
- 307
-
Kinetics of inhibition of MAO-B by N-(2-aminoethyl)-p-chlorobenzamide (Ro 16-6491)and analoguesMullan, E. L. / Williams, C. H. et al. | 1994
- 313
-
Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzymeWouters, J. / Moureau, F. / Vercauteren, D. P. / Evrard, G. et al. | 1994
- 321
-
Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findingsHenriot, S. / Kuhn, C. / Kettler, R. / Da Prada, M. et al. | 1994
- 327
-
Food-derived heterocyclic amines, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole and related amines, as inhibitors of monoamine metabolismMaruyama, W. / Ota, A. / Takahashi, A. / Nagatsu, T. et al. | 1994
- 335
-
Chronopharmacological study of moclobemide effect on the rat pineal melatonin biosynthesisOxenkrug, G. F. / Requintina, P. J. / White, K. / Yuwiler, A. et al. | 1994
- 339
-
Biochemical pharmacology of befloxatone (MD 370503), a new potent reversible MAO-A inhibitorRovei, V. / Caille, D. / Curet, O. / Ego, D. et al. | 1994
- 349
-
Effects of befloxatone, a new potent reversible MAO-A inhibitor, on cortex and striatum monoamines in freely moving ratsCuret, O. / Damoiseau, G. / Labaune, J.-P. / Rovel, V. et al. | 1994
- 357
-
The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving ratsCelada, P. / Bel, N. / Artigas, F. et al. | 1994
- 365
-
In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamineVieira-Coelho, M. A. / Helena Fernandes, M. / Soares-da-Silva, P. et al. | 1994
- 371
-
Pharmacodynamics of MDL 72974A: absence of effect on the pressor response to oral tyramineHinze, C. / Kaschube, M. / Hardenberg, J. et al. | 1994
- 377
-
The acute effect of the bioprecursor of the selective brain MAO-A inhibitor, MDL 72392, on rat pineal melatonin biosynthesisOxenkrug, G. F. / Requintina, P. J. / Yuwiler, A. / Palfreyman, M. G. et al. | 1994
- 381
-
Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesisOxenkrug, G. F. / Requintina, P. J. / McIntyre, I. M. / White, K. et al. | 1994
- 387
-
Properties of mammalian tissue-bound semicarbazide-sensitive amine oxidase: possible clues to its physiological function?Lyles, G. A. et al. | 1994
- 397
-
Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implicationsYu, P. H. / Davis, B. A. / Boulton, A. A. / Zuo, D. M. et al. | 1994
- 407
-
Haloallylamine inhibitors of MAO and SSAO and their therapeutic potentialPalfreyman, M. G. / McDonald, I. A. / Bey, P. / Danzin, C. et al. | 1994
- 415
-
Several aspects on the amino oxidation by semicarbazide-sensitive amine oxidase (SSAO) from bovine lungLizcano, J. M. / Fernandez de Arriba, A. / Lyles, G. A. / Unzeta, M. et al. | 1994
- 421
-
Semicarbazide-sensitive amine oxidase activity of guinea pig dorsal skinBuffoni, F. / Cambi, S. / Banchelli, G. / Ignesti, G. et al. | 1994
- 427
-
Semicarbazide-sensitive amine oxidases in sheep plasma: interactions with some substrates and inhibitorsCrosbie, A. E. / Callingham, B. A. et al. | 1994
- 433
-
Location of the active site of rat vascular semicarbazide-sensitive amine oxidaseHolt, A. / Callingham, B. A. et al. | 1994
- 439
-
The ex vivo effects of procarbazine and methylhydrazine on some rat amine oxidase activitiesHolt, A. / Callingham, B. A. et al. | 1994
- 445
-
Histaminase activity of mesenteric artery of the ratBanchelli, G. / Ignesti, G. / Pirisino, R. / Raimondi, L. et al. | 1994